cirrhosis of the liver are knownto have low levels of circulating testosterone, associated with relatively high levels of estrogen, and of ganadotropins1".
The major mechanism responsible for subnormal circulating testosterone levels in cirrhosis, therefore, seems to be due to the dysfunction of the testis. Recent studies have revealed also that there is abnormal metabolism of endogenous and exogeneous testosterones~. These studies provide supporting evidence that primary gonadal dysfunction exists in male cirrhosis patients.
However, since ethanol consumption is known to act to increase the metabolic clearance rate of testosterone and to inhibit Leydig cell functionll"1 , low levels of circulating testosterone should be elucidated in regard to etiologies and hepatic dysfunction in cirrhosis patients.
The observation that plasma testosterone levels in normal men rise after the administration of an intra-muscular injection of human chorionic Gonadal function was studied principally within one month of entry. After fasting overnight, blood samples were obtained at 7:00 am, and hCG was administered intramuscularly at 3000 IU daily for 3 days. On the 4th day, blood samples were again obtained at 7:00 am. Plasma levels of testosterone were determined by specific ratioimmunoassay. Gonadal function was expressed as basal plasma testosterone levels and the increase of plasma testosterone levels by hCG administration.
RESULTS
The clinical, histological and biochemical findings of the 39 subjects studied are shown in Table 1 . Because control subjects had been selected roughly age matched to cirrhosis patients, patients with chronic hepatitis and alcoholic liver disease belong to a slightly younger age group than the control subjects.
As shown in Table 2 
